Usefulness of a Preemptive Strategy after Three Months of Antiviral Prophylaxis for Cytomegalovirus in Kidney Transplant Recipients.

被引：0
|
作者：
Boillat, Noemie [1 ,2 ]
Pacual, Manuel [2 ]
Venetz, Jean-Pierre [2 ]
Meylan, Pascal R. [1 ,2 ]
Manuel, Oriol [1 ,2 ]
机构：
[1] CHUV, Infect Dis Serv, Lausanne, Switzerland
[2] CHUV, Transplantat Ctr, Lausanne, Switzerland
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [1] Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
    Blanco, Noemie Boillat
    Pascual, Manuel
    Venetz, Jean-Pierre
    Nseir, Ghaleb
    Meylan, Pascal R.
    Manuel, Oriol
    TRANSPLANTATION, 2011, 91 (02) : 251 - 255
  • [2] Comparison of CMV prophylaxis and preemptive therapy in liver and kidney transplant recipients.
    Taber, DJ
    Dupuis, RE
    Hollar, KD
    Meehan, A
    Rodegast, B
    Salm, J
    Zacks, S
    Shrestha, R
    Gerber, D
    Johnson, MW
    TRANSPLANTATION, 2000, 69 (08) : S181 - S181
  • [3] Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients
    Camus, Christophe
    Poinot, Melanie
    Pronier, Charlotte
    Rayar, Michel
    Le Neillon, Anne
    Latournerie, Marianne
    Lagathu, Gisele
    Revest, Matthieu
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (03)
  • [4] Randomized trial of preemptive valganciclovir therapy versus valacyclovir prophylaxis for the management of cytomegalovirus infection in kidney transplant recipients.
    Reischig, Tomas
    Jindra, Pavel
    Klaboch, Jan
    Svecova, Miroslava
    Hes, Ondrej
    Treska, Vladislav
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 506 - 506
  • [5] Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis
    Chaiyapak, Thanaporn
    Borges, Karlota
    Williams, Angela
    Banh, Tonny
    Vasilevska-Ristovska, Jovanka
    Allen, Upton
    Parekh, Rulan S.
    Hebert, Diane
    TRANSPLANTATION, 2018, 102 (08) : 1391 - 1396
  • [6] Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients
    Liu, Amy W.
    Jutivorakool, Kamonwan
    Fisher, Cynthia E.
    Rakita, Robert M.
    Reyes, Jorge D.
    Bhattacharya, Renuka B.
    Jerome, Keith R.
    Limaye, Ajit P.
    TRANSPLANTATION, 2018, 102 (04) : 632 - 639
  • [7] Valganciclovir prophylaxis for cytomegalovirus disease in kidney and simultaneous pancreas-kidney transplant recipients.
    Ciancio, G
    Burke, G
    Suzart, K
    Vaidya, A
    Roth, D
    Kupin, W
    Mattiazzi, A
    Miller, J
    JOURNAL OF UROLOGY, 2002, 167 (04): : 371 - 371
  • [8] Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy
    Singh, Nina
    REVIEWS IN MEDICAL VIROLOGY, 2006, 16 (05) : 281 - 287
  • [9] Preemptive Therapy vs Antiviral Prophylaxis in Cytomegalovirus-Seronegative Liver Transplant Recipients With Seropositive Donors
    Roberts, Matthew B.
    Gandhi, Ronak G.
    Kotton, Camille N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1107 - 1108
  • [10] Seasonal Variation of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Jorgenson, M.
    Astor, B.
    Saddler, C.
    Smith, J.
    Aziz, F.
    Mandelbrot, D.
    Garg, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 782 - 782
12345